Hacker News
- Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers http://www.nytimes.com/2015/10/05/business/valeants-drug-price-strategy-enriches-it-but-infuriates-patients-and-lawmakers.html?WT.nav=top-news&action=click&hp=&module=first-column-region&pgtype=Homepage®ion=top-news 62 comments
Linking pages
- Fed Up With Drug Companies, Hospitals Decide to Start Their Own - The New York Times https://mobile.nytimes.com/2018/01/18/health/drug-prices-hospitals.html 367 comments
- As McKinsey Sells Advice, Its Hedge Fund May Have a Stake in the Outcome - The New York Times https://www.nytimes.com/2019/02/19/business/mckinsey-hedge-fund.html 103 comments
- Valeant Pharmaceuticals’ Novel Business Approach Made It a Wall Street Darling — Then a Pariah http://nymag.com/daily/intelligencer/2016/01/valeant-wall-st-darling-to-pariah.html 17 comments
- Drug Prices Keep Rising Despite Intense Criticism - The New York Times http://www.nytimes.com/2016/04/27/business/drug-prices-keep-rising-despite-intense-criticism.html?amp%3Baction=click&%3Bclicksource=story-heading&%3Bmodule=first-column-region&%3Bpgtype=homepage&%3Bregion=top-news&%3Bwt.nav=top-news&hp= 17 comments
Related searches:
Search whole site: site:www.nytimes.com
Search title: Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers
See how to search.